Product Details
| Product Name:
Tenatumomab |
CAS No.:
1412891-40-7 |
| Purity:
> 95% |
Supply Ability:
10g |
| Release date:
2026/05/21 |
Product Introduction
Bioactivity
| Name | Tenatumomab |
| Description | Tenatumomab (ST2146) is a murine anti-tenascin-C monoclonal antibody used in the study of immune system diseases and lymphomas. |
| In vitro | Compared to other tenascin-targeting monoclonal antibodies, Tenatumomab (at 2-5 μg/mL for 16 h) retains 50% of its immunoreactivity after biotinylation [2]. |
| In vivo | Tenatumomab (4 μg per mouse; intravenous injection; single dose) exhibited a biodistribution associated with the expression of low and high tension proteins in nude mice xenografted with human HT-29 colon carcinoma cells and/or human U-118MG glioblastoma cells [2]. |
| Storage | Store at low temperature
-20°C for 1 year
Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | Tenatumomab |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
|
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States